Lantus for Diabetic Patients Treated in Clalit Outpatient Clinics.
Phase of Trial: Phase III
Latest Information Update: 07 Mar 2012
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Lapas-II
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 07 Mar 2012 Planned end date changed from 1 May 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.
- 07 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.